Peanut Oral Immunotherapy in Children: IMPACT Follow Up Study
Status:
Completed
Trial end date:
2020-10-07
Target enrollment:
Participant gender:
Summary
This application is being submitted as a follow-up to Protocol "Oral Immunotherapy for
Induction of Tolerance in Peanut Allergic Children-The IMPACT Study." The IMPACT study was a
double-blind, placebo-controlled study of peanut oral immunotherapy in children 12-48 months
of age. As part this protocol, all participants who received placebo treatment were promised
the opportunity to receive open label treatment at the conclusion of the double-blind phase
and initial follow-up. At the time of submitting that protocol, the investigator did not
specify any detailed protocol for the open label crossover treatment, as this is an evolving
field, but the investigator is now ready to offer this open label treatment as promised.